澳门太阳游戏城app官网入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

TAK1 Regulates Endothelial Integrity Through Stabilization of Junctions via GSK3β and FoxO1

biorxiv. 2019; 
Sushil C. Regmi, Dheeraj Soni, Dong-Mei Wang, Stephen M. Vogel, Asrar B. Malik, Chinnaswamy Tiruppathi
Products/Services Used Details Operation
Gene Synthesis Protease-activated receptor 1 (PAR-1)-activating peptide (TFLLRNPNDK-NH2) was custom synthesized as the C-terminal amide with a purity of > 95% by Genscript (Piscataway, NJ). Get A Quote

摘要

TLR4 signaling in endothelial cells (ECs) induces vascular injury by disrupting the endothelial junctional barrier. However, it is not known whether TLR4 signaling can also promote endothelial barrier repair after vascular injury. Here we addressed the role of TAK1 activation downstream of TLR4 in the mechanism of vascular integrity. In inducible EC-restricted TAK1 knockout (TAK1iΔEC) mice, the endothelial barrier was compromised. Blocking TAK1 activity caused spontaneous loss of the endothelial barrier. Importantly, TAK1 inactivated GSK3β via AKT to prevent β-catenin downregulation. We observed in ECs of GSK3βiΔEC mice an increase in β-catenin transfer to the nucleus to form a complex with transcriptio... More

关键词